These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22758917)

  • 1. Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.
    McEnaney PJ; Parker CG; Zhang AX; Spiegel DA
    ACS Chem Biol; 2012 Jul; 7(7):1139-51. PubMed ID: 22758917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators.
    Jakobsche CE; Parker CG; Tao RN; Kolesnikova MD; Douglass EF; Spiegel DA
    ACS Chem Biol; 2013 Nov; 8(11):2404-11. PubMed ID: 24053626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic Applications of Antibody-Based Systems in Human Diseases.
    Ding F; Gao Y; He X; Zhang Y
    J Biomed Nanotechnol; 2018 Mar; 14(3):405-429. PubMed ID: 29663918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cells as anti-cancer therapeutic targets and tools.
    Johansson M; Tan T; de Visser KE; Coussens LM
    J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent Stabilization of Antibody Recruitment Enhances Immune Recognition of Cancer Targets.
    Kapcan E; Lake B; Yang Z; Zhang A; Miller MS; Rullo AF
    Biochemistry; 2021 May; 60(19):1447-1458. PubMed ID: 33930269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology's Coming of Age.
    Kaufmann SHE
    Front Immunol; 2019; 10():684. PubMed ID: 31001278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming urokinase into an antibody-recruiting anticancer agent.
    Jakobsche CE; McEnaney PJ; Zhang AX; Spiegel DA
    ACS Chem Biol; 2012 Feb; 7(2):316-21. PubMed ID: 22098560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of Pathogenic Fungi with Small-Molecule Immunotherapeutics.
    Chirkin E; Muthusamy V; Mann P; Roemer T; Nantermet PG; Spiegel DA
    Angew Chem Int Ed Engl; 2017 Oct; 56(42):13036-13040. PubMed ID: 28793176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.
    Jackson DC; Purcell AW; Fitzmaurice CJ; Zeng W; Hart DN
    Curr Drug Targets; 2002 Apr; 3(2):175-96. PubMed ID: 11958299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy enhancement of anti-tumor immunity.
    Brackett CM; Gollnick SO
    Photochem Photobiol Sci; 2011 May; 10(5):649-52. PubMed ID: 21253659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruiting dendritic cells to improve antibody therapy of cancer.
    Dhodapkar KM; Dhodapkar MV
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6243-4. PubMed ID: 15851655
    [No Abstract]   [Full Text] [Related]  

  • 16. HER1-based vaccine: Simultaneous activation of humoral and cellular immune response.
    Bergado Báez G; Hernández Fernández DR; Mazorra Herrera Z; Sánchez Ramírez B
    Semin Oncol; 2018 Jan; 45(1-2):75-83. PubMed ID: 30318087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.
    Sasaki K; Harada M; Yoshikawa T; Tagawa H; Harada Y; Yonemitsu Y; Ryujin T; Kishimura A; Mori T; Katayama Y
    Chembiochem; 2021 Feb; 22(3):496-500. PubMed ID: 32969164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological problems in oncology (author's transl)].
    Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
    Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a Rational Design of Antibody-Recruiting Molecules through a Computational Microscopy View of their Interactions with the Target Antibody.
    Uvyn A; Tonneaux C; Fossépré M; Ouvrier-Buffet A; De Geest BG; Surin M
    Chemistry; 2023 May; 29(30):e202300474. PubMed ID: 36862311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of immunopharmacology: IUPHAR Review 16.
    Tiligada E; Ishii M; Riccardi C; Spedding M; Simon HU; Teixeira MM; Cuervo ML; Holgate ST; Levi-Schaffer F
    Br J Pharmacol; 2015 Sep; 172(17):4217-27. PubMed ID: 26173913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.